- Company Overview for RIB-X THERAPEUTICS LIMITED (05532277)
- Filing history for RIB-X THERAPEUTICS LIMITED (05532277)
- People for RIB-X THERAPEUTICS LIMITED (05532277)
- More for RIB-X THERAPEUTICS LIMITED (05532277)
Persons with significant control: 1 person with significant control / 0 statements
Melinta Therapeutics Inc
- Correspondence address
- 300 George Street, Suite 301, New Haven, Connecticut, United States, 06511
- Notified on
- 5 January 2018
- Governing law
- Legal form
- Delaware Incorporated Company
- Nature of control
- Ownership of voting rights - 75% or more
- Right to appoint or remove directors
Statement Withdrawn
- The company knows or has reasonable cause to believe that there is no registrable person or registrable relevant legal entity in relation to the company
- Notified on
- 9 August 2016
- Withdrawn on
- 5 January 2018